Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01377142 · ClinicalTrials.gov registry record
Vaginal Uphold Hysteropexy and Laparoscopic Sacral Hysteropexy for the Treatment of Uterovaginal Pelvic Organ Prolapse
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 148
- Enrollment target
NCT01377142: Completed study, sponsored by The Cleveland Clinic.
NCT01377142 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01377142 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate surgical success or failure one year after surgery for pelvic organ prolapse.
Primary Outcome
Anatomic sure is defined as cervix above mid-vagina, and no prolapse beyond the hymen and no surgical treatment for pelvic organ prolapse or pessary use. Symptomatic cure is defined as the absence of vaginal bulge symptoms as indicated by a negative response question 3 of the pelvic floor distress inventory- 20.
Interventions
- DEVICE Laparoscopic sacral hysteropexy
- DEVICE Vaginal mesh hysteropexy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-12 |
What the finished NCT01377142 record still lists
NCT01377142 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Laparoscopic sacral hysteropexy is the first listed.
NCT01377142 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01377142 about?
NCT01377142 is a clinical study titled "Vaginal Uphold Hysteropexy and Laparoscopic Sacral Hysteropexy for the Treatment of Uterovaginal Pelvic Organ Prolapse". The purpose of this study is to evaluate surgical success or failure one year after surgery for pelvic organ prolapse.
What is the current status of trial NCT01377142?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2011-06. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01377142?
The interventions under investigation include: Laparoscopic sacral hysteropexy (DEVICE), Vaginal mesh hysteropexy (DEVICE).
Who is sponsoring clinical trial NCT01377142?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia